All Publications

Pages

1. • Journal article

   • 

   Vaccination of a Melanoma Patient with Mature Dendritic Cells Pulsed with MAGE-3 Peptides Triggers the Activity of Nonvaccine Anti-Tumor Cells.

   Carrasco, Javier[UCL] Van Pel, Aline[UCL] Neyns, Bart Lethé, Bernard Brasseur, Francis Renkvist, Nicolina van der Bruggen, Pierre[UCL] van Baren, Nicolas Paulus, Robert Thielemans, Kris Boon, Thierry Godelaine, Danièle (2008) Journal of Immunology — Vol. 180, no. 5, p. 3585-93 (2008)
2. • Journal article

   • 

   Human periostin gene expression in normal tissues, tumors and melanoma: evidences for periostin production by both stromal and melanoma cells

   Tilman, Gaëlle[UCL] Mattiussi, Marina[UCL] Brasseur, Francis[UCL] van Baren, Nicolas[UCL] Decottignies, Anabelle[UCL] (2007) Molecular Cancer — Vol. 6, p. 80 [1-13] (2007)
3. • Journal article

   • 

   Hemorrhagic regression of melanoma metastases during therapeutic vaccination: a report of three cases.

   Pierret, Lauranne van Baren, Nicolas[UCL] Bonehill, Aude Corthals, Jurgen Van Nuffel, An Heirman, Carlo Roelandt, Truus De Coninck, Arlette Van Riet, Ivan Degreef, Ellen Goossens, Annieta Verfaillie, Guy Roseeuw, Diane Thielemans, Kris Neyns, Bart (2009) Melanoma research — (2009)
4. • Journal article

   • 

   Is There a Clinical Future for IDO1 Inhibitors After the Failure of Epacadostat in Melanoma?

   Van den Eynde, Benoît[UCL] van Baren, Nicolas[UCL] Baurain, Jean-François[UCL] (2020) Annual review of cancer biology — Vol. 4, no. 1, p. 241-256 (2020)
5. • Journal article

   • 

   Tryptophan 2,3-Dioxygenase Expression Identified in Human Hepatocellular Carcinoma Cells and in Intratumoral Pericytes of Most Cancers.

   Hoffmann, Delia[UCL] Dvorakova, Tereza[UCL] Stroobant, Vincent[UCL] Bouzin, Caroline[UCL] Daumerie, Aurélie[UCL] Solvay, Marie[UCL] Klaessens, Simon[UCL] Letellier, Marie-Claire Renauld, Jean-Christophe[UCL] van Baren, Nicolas[UCL] Lelotte, Julie[UCL] Marbaix, Etienne[UCL] Van den Eynde, Benoît[UCL] (2020) Cancer immunology research — Vol. 8, no. 1, p. 19-31 (2020)
6. • Dissertation

   • 

   Vaccination of advanced melanoma patients with an Alvac virus encoding mage antigens : clinical and immunological effects

   van Baren, Nicolas[UCL] (2007)
7. • Journal article

   • 

   Genes encoding tumor-specific antigens are expressed in human myeloma cells

   van Baren, Nicolas[UCL] Brasseur, Francis[UCL] Godelaine, Danièle[UCL] Hames, Gérald[UCL] Ferrant, Augustin[UCL] Lehmann, Frédéric André, Marc[UCL] Ravoet, Christophe[UCL] Doyen, Chantal[UCL] Spagnoli, Giulio C. Bakkus, Marleen Thielemans, Kris Boon-Falleur, Thierry[UCL] (1999) Blood — Vol. 94, no. 4, p. 1156-1164 (1999)
8. • Speech

   • 

   Neogenesis of lymphoid structures in metastatic melanoma.

   van Baren, Nicolas[UCL] (2012) NIBIT (Italian Network for Tumor Biotherapy) 10th Annual Meeting — Siena (Italy)
9. • Journal article

   • 

   A novel cancer-germline transcript carrying pro-metastatic miR-105 and TET-targeting miR-767 induced by DNA hypomethylation in tumors.

   Loriot, Axelle Van Tongelen, Aurélie Blanco, Jordi Klaessens, Simon Cannuyer, Julie van Baren, Nicolas Decottignies, Anabelle De Smet, Charles (2014) Epigenetics — Vol. 9, no. 8, p. 1163-1171 (2014)
10. • Speech

    • 

    Invited Lecture: Clinical and immunological effects in melanoma patients vaccinated with MAGE antigens.

    van Baren, Nicolas[UCL] (2006) The Second International Cancer Vaccine Meeting. — Borgo San Luigi, Monteriggioni (Siena, Italy)
11. • Journal article

    • 

    Mutations of the beta2-microglobulin gene result in a lack of HLA class I molecules on melanoma cells of two patients immunized with MAGE peptides.

    Benitez, R Godelaine, Danièle[UCL] Lopez-Nevot, M A Brasseur, F Jiménez, P Marchand, M Oliva, M R van Baren, Nicolas[UCL] Cabrera, T Andry, G Landry, C Ruiz-Cabello, F Boon, Thierry[UCL] Garrido, F (1998) Tissue Antigens — Vol. 52, no.6, p. 520-9 (1998)
12. • Journal article

    • 

    Extensive Profiling of the Expression of the Indoleamine 2,3-Dioxygenase 1 Protein in Normal and Tumoral Human Tissues

    Théate, Ivan[UCL] van Baren, Nicolas[UCL] Pilotte, Luc Moulin, Pierre Larrieu, Pierre[UCL] Renauld, Jean-Christophe[UCL] Hervé, Caroline[UCL] Gutierrez-Roelens, Ilse[UCL] Marbaix, Etienne[UCL] Sempoux, Christine[UCL] Van den Eynde, Benoît[UCL] (2015) Cancer Immunology Research — Vol. 3, no. 2, p. 161-72 (2015)
13. • Journal article

    • 

    Therapeutic activity of GARP:TGF-β1 blockade in murine primary myelofibrosis.

    Lecomte, Sara[UCL] Devreux, Julien[UCL] de Streel, Grégoire[UCL] van Baren, Nicolas[UCL] Havelange, Violaine[UCL] Schröder, David[UCL] Vaherto, Noora[UCL] Vanhaver, Christophe[UCL] Vanderaa, Christophe[UCL] Dupuis, Noémie[UCL] Pecquet, Christian[UCL] Coulie, Pierre G.[UCL] Constantinescu, Stefan N[UCL] Lucas, Sophie[UCL] (2023) Blood — Vol. 141, no.5, p. 490-502 (2023)
14. • Journal article

    • 

    Phase 1/2 study of subcutaneous and intradermal immunization with a recombinant MAGE-3 protein in patients with detectable metastatic melanoma

    Kruit, WHJ Van Ojik, Heidi H. Brichard, Vincent G.[UCL] Escudier, B Dorval, T Dréno, B. Patel, P van Baren, Nicolas[UCL] Avril, Marie-Françoise Piperno, S Khammari, A Stas, M. Ritter, G. LETHE, Bernard[UCL] GODELAINE, Danièle[UCL] Brasseur, Francis[UCL] Zhang, Yi[UCL] van der Bruggen, Pierre[UCL] Boon, Thierry[UCL] Eggermont, AMM Marchand, Marie[UCL] (2005) International Journal of Cancer — Vol. 117, no. 4, p. 596-604 (2005)
15. • Journal article

    • 

    New vaccination approaches in melanoma with tumor antigens recognized by T lymphocytes.

    Marchand, Marie[UCL] van Baren, Nicolas[UCL] Raimundo, A.[UCL] Humblet, Yves[UCL] Tromme, Isabelle[UCL] (2002) Nederlands Tijdschrift voor Dermatologie en Venerologie — Vol. 12, p. 344-345 (2002)
16. • Journal article

    • 

    Peptide-based cancer vaccines

    Machiels, Jean-Pascal[UCL] van Baren, Nicolas[UCL] Marchand, Marie[UCL] (2002) Seminars in Oncology — Vol. 29, no. 5, p. 494-502 (2002)
17. • Journal article

    • 

    Defining the prognostic value for galectin-3 in cutaneous melanoma.

    Vereecken, P Ghanem, G Morandini, R Suciu, S van Baren, Nicolas[UCL] Heenen, M (2007) The Journal of International Medical Research — Vol. 35, no. 5, p. 731-732 (2007)
18. • BookChapter

    • 

    Improving the clinical efficacy of cancer vaccines by targeting immune suppression in human tumors

    Demotte, Nathalie[UCL] Antonopoulos, Aristotelis Baurain, Jean-François[UCL] Wieers, Grégoire[UCL] van Baren, Nicolas[UCL] van der Bruggen, Pierre[UCL] (2012) Galectins and Disease Implications for Targeted Therapeutics. Proceedings of the First Symposium on Galectin-Related Therapeutics — [ISBN : 978-0-8412-2880-1]
19. • Journal article

    • 

    Plasma cells in primary melanoma. Prognostic significance and possible role of IgA.

    Bosisio, Francesca M Wilmott, James S Volders, Nathalie Mercier, Marjorie[UCL] Wouters, Jasper Stas, Marguerite Blokx, Willeke Am Massi, Daniela Thompson, John F Scolyer, Richard A van Baren, Nicolas[UCL] van den Oord, Joost J (2016) Modern Pathology — Vol. 29, no. 4, p. 347-358 (2016)
20. • Speech

    • 

    Invited Lecture: Where do we go with peptides in cancer vaccines ?

    van Baren, Nicolas[UCL] Baurain, Jean-François[UCL] (2008) 2d meeting of the Cancerimmunotherapy Consortium — Brussels (Belgium)
21. • Journal article

    • 

    Ex vivo detectable activation of Melan-A-specific T cells correlating with inflammatory skin reactions in melanoma patients vaccinated with peptides in IFA.

    Liénard, Danielle Rimoldi, Donata Marchand, Marie Dietrich, Pierre-Yves van Baren, Nicolas[UCL] Geldhof, Christine Batard, Pascal Guillaume, Philippe Ayyoub, Maha Pittet, Mikaël J Zippelius, Alfred Fleischhauer, Katharina Lejeune, Ferdy Cerottini, Jean-Charles Romero, Pedro Speiser, Daniel E (2004) Cancer Immunity — Vol. 4, p. 4 (2004)
22. • Speech

    • 

    Monitoring CTL responses in cancer patients vaccinated with a tumor-specific antigen.

    van Baren, Nicolas[UCL] (2008) Meeting of the International Society for Cellular Therapy — Antwerp
23. • Speech

    • 

    Immunotherapy of cancer. Where are we ?

    van Baren, Nicolas[UCL] (2009) 24th meeting of the Belgian Hematological Society — Oostende (Belgium)
24. • Speech

    • 

    Invited Lecture: Achievements with immunotherapy of cancers.

    van Baren, Nicolas[UCL] Marchand, Marie[UCL] Boon, Thierry[UCL] (1999) Eurocancer 99 — Paris (France)
25. • Journal article

    • 

    Tryptophan-degrading enzymes in tumoral immune resistance

    van Baren, Nicolas[UCL] Van den Eynde, Benoît[UCL] (2015) Frontiers in Immunology — Vol. 6, no. 34, p. 1-9 (03/02/2015)

Pages